Editorial: Ischemic Myocardial Injury and Protection: From Bench to Bedside.
作者信息
Gong Hui, Tan Hongmei, Tang Yaoliang
机构信息
Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
Department of Pathophysiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
出版信息
Front Cardiovasc Med. 2022 May 24;9:940298. doi: 10.3389/fcvm.2022.940298. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Ischemic Myocardial Injury and Protection: From Bench to Bedside.社论：缺血性心肌损伤与保护：从 bench 到 bedside 。 （注：bench to bedside 直译为“从实验室到临床” ，这里保留英文未翻译，因为在医学领域这是一个常用的固定表达，直接保留英文更符合专业语境习惯 ）
Front Cardiovasc Med. 2022 May 24;9:940298. doi: 10.3389/fcvm.2022.940298. eCollection 2022.
2
Diagnostic significance of stimulating growth factor ST2 and N-terminal prohormone of brain natriuretic peptide NT-PROBNP in patients with ischemic heart disease in the setting of metabolic syndrome.代谢综合征患者缺血性心脏病患者中生长刺激因子 ST2 和脑钠肽 N 末端前体 NT-PROBNP 的诊断意义。
Pol Merkur Lekarski. 2021 Aug 16;49(292):249-251.
3
The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study.1990 年和 2010 年全球缺血性心脏病负担：2010 年全球疾病负担研究。
Circulation. 2014 Apr 8;129(14):1493-501. doi: 10.1161/CIRCULATIONAHA.113.004046. Epub 2014 Feb 26.
4
[Prevalence of metabolic syndrome and association with ischemic heart disease in cardiological outpatients].
Rev Clin Esp. 2006 Jun;206(6):259-65. doi: 10.1157/13088584.
5
Myocardial infarction and ischemic heart disease in overweight and obesity with and without metabolic syndrome.超重和肥胖伴或不伴代谢综合征与心肌梗死和缺血性心脏病。
JAMA Intern Med. 2014 Jan;174(1):15-22. doi: 10.1001/jamainternmed.2013.10522.
6
High-Energy Phosphates and Ischemic Heart Disease: From Bench to Bedside.高能磷酸盐与缺血性心脏病：从实验台到病床边
Front Cardiovasc Med. 2021 Jul 28;8:675608. doi: 10.3389/fcvm.2021.675608. eCollection 2021.
7
[Association of metabolic syndrome with ischemic heart disease among middle-aged Kaunas population].[考纳斯中年人群中代谢综合征与缺血性心脏病的关联]
Medicina (Kaunas). 2005;41(5):435-41.
8
Metabolic syndrome and ischemic heart disease in gout.痛风中的代谢综合征与缺血性心脏病
J Clin Rheumatol. 2004 Jun;10(3):105-9. doi: 10.1097/01.rhu.0000129082.42094.fc.
9
Ability of 201Tl and 123I-BMIPP mismatch to diagnose myocardial ischemia in patients with suspected coronary artery disease.201Tl 和 123I-BMIPP 不匹配诊断可疑冠心病患者心肌缺血的能力。
Ann Nucl Med. 2009 Nov;23(9):793-8. doi: 10.1007/s12149-009-0307-8. Epub 2009 Sep 30.
10
Activation of hypoxia-sensing pathways promotes renal ischemic preconditioning following myocardial infarction.缺氧感应途径的激活可促进心肌梗死后的肾缺血预处理。
Am J Physiol Renal Physiol. 2021 Apr 1;320(4):F569-F577. doi: 10.1152/ajprenal.00476.2020. Epub 2021 Feb 1.
本文引用的文献
1
Exercise and cardiovascular protection: Update and future.运动与心血管保护：最新进展与未来展望。
J Sport Health Sci. 2021 Dec;10(6):607-608. doi: 10.1016/j.jshs.2021.11.001. Epub 2021 Nov 16.
2
Ventricular Arrhythmias in Ischemic Cardiomyopathy-New Avenues for Mechanism-Guided Treatment.缺血性心肌病性室性心律失常——机制指导治疗的新途径。
Cells. 2021 Oct 1;10(10):2629. doi: 10.3390/cells10102629.
3
Association of Coronary Artery Disease and Metabolic Syndrome: Usefulness of Serum Metabolomics Approach.冠状动脉疾病与代谢综合征的关联：血清代谢组学方法的应用。
Front Endocrinol (Lausanne). 2021 Sep 24;12:692893. doi: 10.3389/fendo.2021.692893. eCollection 2021.
4
IGF1-PI3K-induced physiological cardiac hypertrophy: Implications for new heart failure therapies, biomarkers, and predicting cardiotoxicity.IGF1-PI3K 诱导的生理性心肌肥厚：对新型心力衰竭治疗、生物标志物和预测心脏毒性的影响。
J Sport Health Sci. 2021 Dec;10(6):637-647. doi: 10.1016/j.jshs.2020.11.009. Epub 2020 Nov 24.
5
Low density lipoprotein receptor related protein 6 (LRP6) protects heart against oxidative stress by the crosstalk of HSF1 and GSK3β.低密度脂蛋白受体相关蛋白 6（LRP6）通过 HSF1 和 GSK3β 的串扰保护心脏免受氧化应激。
Redox Biol. 2020 Oct;37:101699. doi: 10.1016/j.redox.2020.101699. Epub 2020 Aug 25.
6
Cardiac-specific LRP6 knockout induces lipid accumulation through Drp1/CPT1b pathway in adult mice.心脏特异性 LRP6 敲除通过 Drp1/CPT1b 通路诱导成年小鼠脂质积累。
Cell Tissue Res. 2020 Apr;380(1):143-153. doi: 10.1007/s00441-019-03126-3. Epub 2019 Dec 7.
7
Myocardial ischemia and coronary disease in heart failure.心力衰竭中的心肌缺血和冠状动脉疾病。
Heart Fail Rev. 2020 Jan;25(1):53-65. doi: 10.1007/s10741-019-09831-z.
8
Mortality From Ischemic Heart Disease.缺血性心脏病导致的死亡率
Circ Cardiovasc Qual Outcomes. 2019 Jun;12(6):e005375. doi: 10.1161/CIRCOUTCOMES.118.005375. Epub 2019 Jun 4.
9
Cardiomyocyte-Restricted Low Density Lipoprotein Receptor-Related Protein 6 (LRP6) Deletion Leads to Lethal Dilated Cardiomyopathy Partly Through Drp1 Signaling.心肌细胞特异性低密度脂蛋白受体相关蛋白 6（LRP6）缺失导致致死性扩张型心肌病部分通过 Drp1 信号通路。
Theranostics. 2018 Jan 1;8(3):627-643. doi: 10.7150/thno.22177. eCollection 2018.
10
Protective Actions of H2S in Acute Myocardial Infarction and Heart Failure.硫化氢在急性心肌梗死和心力衰竭中的保护作用
Compr Physiol. 2017 Mar 16;7(2):583-602. doi: 10.1002/cphy.c160023.
Zotero 插件